Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases, today announced ...

One of the issues raised was the steady decline in reimbursements. Unadjusted and adjusted average reimbursement for GI procedures dropped by 7% and 33%, respectively from 2007 to 2022, according to a ...

The study showed that people without the SI gene may have a hard time digesting sugary foods, making them dislike it. The ...

Immunic (IMUX) announced that the data from its phase 1/1b clinical trial of IMU-856, an orally available and systemically acting small molecule modulator that targets SIRT6, has been published in the ...

Screening rates for hepatitis D virus are not ideal among individuals with hepatitis B virus, who also have a higher all-cause mortality rate.

While "excess calories from sugar are an established contributor to obesity and type 2 diabetes," the new findings, published ...

Women have an increased global burden of gallbladder and biliary tract cancer (GBTC) compared with men, according to a study in the Journal of Gastroenterology and Hepatology.

The findings open up the possibility of developing treatments to target the gene in order to help curb population-wide sugar ...

Another "loophole" in colonoscopy reimbursements is the fact that if a colonoscopy becomes diagnostic, patients can expect to pay 15% of the Medicare-approved amount for a physicians' services. In ...

Many bacterial-linked illnesses, such as inflammatory bowel disease or colorectal cancer, are associated with an overgrowth ...